Viewing Study NCT01227902


Ignite Creation Date: 2025-12-25 @ 3:37 AM
Ignite Modification Date: 2025-12-26 @ 2:21 AM
Study NCT ID: NCT01227902
Status: COMPLETED
Last Update Posted: 2014-10-17
First Post: 2010-07-16
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-07
Start Date Type: None
Primary Completion Date: 2012-12
Primary Completion Date Type: ACTUAL
Completion Date: 2012-12
Completion Date Type: ACTUAL
First Submit Date: 2010-07-16
First Submit QC Date: None
Study First Post Date: 2010-10-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2013-07-25
Results First Submit QC Date: None
Results First Post Date: 2013-11-11
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-10-09
Last Update Post Date: 2014-10-17
Last Update Post Date Type: ESTIMATED